On our screens:Stocks with no debt
What is the market doing?
What the tape says about INDV
Indivior Pharmaceuticals, Inc. is +47% over the past year while the S&P 500 is +20%: 26 points ahead of the market.
+47%
1-year return · S&P 500 +20%
- vs 200-day average
- −2.0%
vs 200-day average · below trend, but not far
- RSI (14)
- 14
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 17%
Below its 52-week high
Details›
- Last close2026-09-08
- $34.32
- 1 monthS&P 500 −0.30%
- −11%
- 1 yearS&P 500 +20%
- +47%
- 5 yearsS&P 500 +85%
- +186%
- vs 50-day average$38.37
- −11%
- 52-week high
- $41.47
- 52-week low
- $22.51
- Annualised volatility
- 48%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $204K
| Year | Return |
|---|---|
| 2026 (year to date) | −4.3% |
| 2025 | +189% |
| 2024 | −19% |
| 2023 | −30% |
| 2022 | +26% |
| 2021 | +135% |
| 2020 | +182% |
| 2019 | −61% |
| 2018 | −75% |
| 2017 | +55% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +3.8% |
| Feb | 10 | 5 of 10 | +0.24% |
| Mar | 10 | 4 of 10 | −1.3% |
| Apr | 10 | 8 of 10 | +2.8% |
| May | 10 | 8 of 10 | +5.6% |
| Jun | 10 | 4 of 10 | +3.6% |
| Jul | 11 | 7 of 11 | +13% |
| Aug | 11 | 6 of 11 | +0.35% |
| Sep | 11 | 2 of 11 | −9.8% |
| Oct | 10 | 4 of 10 | +4.4% |
| Nov | 10 | 6 of 10 | −0.94% |
| Dec | 10 | 7 of 10 | +2.8% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #19 of 29 by Smart Score